UB Paderborn / Katalog / Suche / in CDI

Nitric oxide‐donating statin improves multiple functions of circulating angiogenic cells

British journal of pharmacology, 2011-09, Vol.164 (2b), p.570-583

2011

Link zum Volltext

Verfügbarkeit prüfen

Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type‐1 diabetic mice

British journal of pharmacology, 2007-04, Vol.150 (7), p.873-882

2007

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury

European journal of pharmacology, 2002-06, Vol.447 (1), p.59-65

2002

Link zum Volltext

Verfügbarkeit prüfen

Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis

Gastroenterology (New York, N.Y. 1943), 2011-10, Vol.141 (4), p.1314-1322.e5

2011

Link zum Volltext

Verfügbarkeit prüfen

A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs

Experimental eye research, 2011-09, Vol.93 (3), p.243-249

2011

Link zum Volltext

Verfügbarkeit prüfen

A(2A) adenosine receptors in human peripheral blood cells

British journal of pharmacology, 2000-01, Vol.129 (1), p.2-11

2000

Link zum Volltext

Verfügbarkeit prüfen

P.11.3 Long term treatment with naproxcinod significantly improves skeletal and cardiac function in mdx mouse model of dystrophy

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.799-799

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1999-01, Vol.359 (1), p.7-10

1999

Link zum Volltext

Verfügbarkeit prüfen

A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model

British journal of ophthalmology, 2006-11, Vol.90 (11), p.1414-1419

2006

Link zum Volltext

Verfügbarkeit prüfen

Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

Journal of neurochemistry, 2004-11, Vol.91 (3), p.521-536

2004

Link zum Volltext

Verfügbarkeit prüfen

A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2554-2562

2005

Link zum Volltext

Verfügbarkeit prüfen

570 THE CINOD NCX 429 EXERTS ANTI-INFLAMMATORY EFFECTS IN ISOLATED HUMAN MONOCYTES AND MACROPHAGES

Osteoarthritis and cartilage, 2010, Vol.18, p.S255-S255

2010

Link zum Volltext

Verfügbarkeit prüfen

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1996-02, Vol.276 (2), p.398

1996

Link zum Volltext

Verfügbarkeit prüfen

Lack of the nociceptin receptor does not affect acute or chronic nociception in mice

Peptides (New York, N.Y. : 1980), 2002-09, Vol.23 (9), p.1589-1596

2002

Link zum Volltext

Verfügbarkeit prüfen

Nociceptin and the ORL‐1 ligand [Phe1ψ (CH2‐NH)Gly2]nociceptin(1‐13)NH2 exert anti‐opioid effects in the Freund's adjuvant‐induced arthritic rat model of chronic pain

British journal of pharmacology, 1999-11, Vol.128 (6), p.1252-1258

1999

Link zum Volltext

Verfügbarkeit prüfen

Presenilin-1 Regulates the Neuronal Threshold to Excitotoxicity Both Physiologically and Pathologically

Proceedings of the National Academy of Sciences - PNAS, 2000-11, Vol.97 (23), p.12822-12827

2000

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory Effect of NO-Releasing Ciprofloxacin (NCX 976) on Mycobacterium tuberculosis Survival

Antimicrobial Agents and Chemotherapy, 2003-07, Vol.47 (7), p.2299-2302

2003

Link zum Volltext

Verfügbarkeit prüfen

Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy

Human molecular genetics, 2014-06, Vol.23 (12), p.3239-3249

2014

Link zum Volltext

Verfügbarkeit prüfen

Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes

British journal of pharmacology, 1996-04, Vol.117 (7), p.1381-1386

1996

Link zum Volltext

Verfügbarkeit prüfen

Modulation of β‐amyloid metabolism by non‐steroidal anti‐inflammatory drugs in neuronal cell cultures

Journal of neurochemistry, 2004-01, Vol.88 (2), p.337-348

2004

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

British journal of pharmacology, 2001-09, Vol.134 (1), p.68-77

2001

Link zum Volltext

Verfügbarkeit prüfen

Nitric Oxide (NO)-Releasing Statin Derivatives, a Class of Drugs Showing Enhanced Antiproliferative and Antiinflammatory Properties

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (22), p.8497-8502

2004

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat

The Journal of pharmacology and experimental therapeutics, 1993-08, Vol.266 (2), p.726

1993

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage

The European journal of neuroscience, 2000-07, Vol.12 (7), p.2265-2272

2000

Link zum Volltext

Verfügbarkeit prüfen

Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents

Annals of the New York Academy of Sciences, 2002-05, Vol.962 (1), p.360-371

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Nitric oxide‐donating statin improves multiple functions of circulating angiogenic cells

Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type‐1 diabetic mice

Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury

Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis

A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs

A(2A) adenosine receptors in human peripheral blood cells

P.11.3 Long term treatment with naproxcinod significantly improves skeletal and cardiac function in mdx mouse model of dystrophy

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model

Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression

570 THE CINOD NCX 429 EXERTS ANTI-INFLAMMATORY EFFECTS IN ISOLATED HUMAN MONOCYTES AND MACROPHAGES

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist

Lack of the nociceptin receptor does not affect acute or chronic nociception in mice

Nociceptin and the ORL‐1 ligand [Phe1ψ (CH2‐NH)Gly2]nociceptin(1‐13)NH2 exert anti‐opioid effects in the Freund's adjuvant‐induced arthritic rat model of chronic pain

Presenilin-1 Regulates the Neuronal Threshold to Excitotoxicity Both Physiologically and Pathologically

Inhibitory Effect of NO-Releasing Ciprofloxacin (NCX 976) on Mycobacterium tuberculosis Survival

Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy

Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes

Modulation of β‐amyloid metabolism by non‐steroidal anti‐inflammatory drugs in neuronal cell cultures

Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

Nitric Oxide (NO)-Releasing Statin Derivatives, a Class of Drugs Showing Enhanced Antiproliferative and Antiinflammatory Properties

Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat

Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage

Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents

Suchergebnisse filtern